MicroRNAs Targeting MYCN in Neuroblastoma
Author Information
Author(s): Buechner J, Tømte E, Haug B H, Henriksen J R, Løkke C, Flægstad T, Einvik C
Primary Institution: University Hospital of North-Norway
Hypothesis
This study investigates the proto-oncogene MYCN as a target for miRNA regulation.
Conclusion
The tumour-suppressor miRNAs let-7 and mir-101 target MYCN and inhibit proliferation and clonogenic growth of MYCN-amplified neuroblastoma cells.
Supporting Evidence
- MYCN is targeted by several miRNAs, including let-7 and mir-101.
- Overexpression of let-7e and mir-202 significantly inhibited cell proliferation.
- miRNAs were shown to suppress endogenous N-myc protein in neuroblastoma cells.
- Mutations in the MYCN 3′UTR were found to be rare and did not affect miRNA binding.
Takeaway
Some tiny molecules called microRNAs can stop a gene called MYCN from making too much of a protein that helps cancer grow, which is important for treating a type of childhood cancer.
Methodology
The study used luciferase reporter assays and cell line experiments to investigate miRNA targeting of MYCN.
Potential Biases
Potential bias in the selection of miRNAs for validation and the specific cell lines used.
Limitations
The study primarily focused on a limited number of miRNAs and cell lines, which may not represent all neuroblastoma cases.
Participant Demographics
The study included genomic DNA samples from 39 primary neuroblastoma tumors, with 34 being MYCN-amplified.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website